These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26402001)

  • 1. Apathy Treatment in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    Rea R; Carotenuto A; Traini E; Fasanaro AM; Manzo V; Amenta F
    J Alzheimers Dis; 2015; 48(2):377-83. PubMed ID: 26402001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Effect of the Association between Donepezil and Choline Alphoscerate on Behavioral Disturbances in Alzheimer's Disease: Interim Results of the ASCOMALVA Trial.
    Carotenuto A; Rea R; Traini E; Fasanaro AM; Ricci G; Manzo V; Amenta F
    J Alzheimers Dis; 2017; 56(2):805-815. PubMed ID: 28035924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the neural effect of switching from donepezil to galantamine based on single-photon emission computed tomography findings in patients with Alzheimer's disease.
    Oka M; Nakaaki S; Negi A; Miyata J; Nakagawa A; Hirono N; Mimura M
    Psychogeriatrics; 2016 Mar; 16(2):121-34. PubMed ID: 26114924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of choline alfoscerate as a combination therapy with donepezil: A mixed double-blind randomized controlled and open-label observation trial.
    Lee W; Kim M
    Medicine (Baltimore); 2024 Jun; 103(24):e38067. PubMed ID: 38875437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in the Treatment of Depression in Patients with Alzheimer's Disease.
    Carotenuto A; Fasanaro AM; Manzo V; Amenta F; Traini E
    J Alzheimers Dis Rep; 2022; 6(1):235-243. PubMed ID: 35719710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Donepezil in Alzheimer's disease: eighteen month results from Southampton Memory Clinic.
    Matthews HP; Korbey J; Wilkinson DG; Rowden J
    Int J Geriatr Psychiatry; 2000 Aug; 15(8):713-20. PubMed ID: 10960883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination treatment in Alzheimer's disease: results of a randomized, controlled trial with cerebrolysin and donepezil.
    Alvarez XA; Cacabelos R; Sampedro C; Couceiro V; Aleixandre M; Vargas M; Linares C; Granizo E; García-Fantini M; Baurecht W; Doppler E; Moessler H
    Curr Alzheimer Res; 2011 Aug; 8(5):583-91. PubMed ID: 21679156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Volume Analysis of Brain Cognitive Areas in Alzheimer's Disease: Interim 3-Year Results from the ASCOMALVA Trial.
    Traini E; Carotenuto A; Fasanaro AM; Amenta F
    J Alzheimers Dis; 2020; 76(1):317-329. PubMed ID: 32508323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cognitive-communication stimulation for Alzheimer's disease patients treated with donepezil.
    Chapman SB; Weiner MF; Rackley A; Hynan LS; Zientz J
    J Speech Lang Hear Res; 2004 Oct; 47(5):1149-63. PubMed ID: 15603468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in regional cerebral blood flow and functional connectivity in the cholinergic pathway associated with cognitive performance in subjects with mild Alzheimer's disease after 12-week donepezil treatment.
    Li W; Antuono PG; Xie C; Chen G; Jones JL; Ward BD; Franczak MB; Goveas JS; Li SJ
    Neuroimage; 2012 Apr; 60(2):1083-91. PubMed ID: 22245641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donepezil delays progression to AD in MCI subjects with depressive symptoms.
    Lu PH; Edland SD; Teng E; Tingus K; Petersen RC; Cummings JL;
    Neurology; 2009 Jun; 72(24):2115-21. PubMed ID: 19528519
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Benefits of Rivastigmine in the Real World Dementia Clinics of the Okayama Rivastigmine Study (ORS).
    Matsuzono K; Sato K; Kono S; Hishikawa N; Ohta Y; Yamashita T; Deguchi K; Nakano Y; Abe K
    J Alzheimers Dis; 2015; 48(3):757-63. PubMed ID: 26402119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The efficacy of donepezil hydrochloride on the Apathy scale in Alzheimer's disease].
    Oguro H; Onoda K; Kobayashi S; Yamaguchi S
    Nihon Ronen Igakkai Zasshi; 2010; 47(5):481-2. PubMed ID: 21116094
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of stimulation therapy and donepezil on cognitive function in Alzheimer's disease. A community based RCT with a two-by-two factorial design.
    Andersen F; Viitanen M; Halvorsen DS; Straume B; Wilsgaard T; Engstad TA
    BMC Neurol; 2012 Jul; 12():59. PubMed ID: 22813231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Transcranial Direct Current Stimulation Combined with Cognitive Training in the Treatment of Apathy in Patients with Alzheimer's Disease: Study Protocol for a Randomized Trial.
    Nguyen JP; Boutoleau-Bretonniere C; Lefaucheur JP; Suarez A; Gaillard H; Chapelet G; Abad S; Van Langhenhove A; Nizard J; de Decker L
    Rev Recent Clin Trials; 2018; 13(4):319-327. PubMed ID: 29658441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and safety of donepezil in Hispanic patients with Alzheimer's disease: a 12-week open-label study.
    Lopez OL; Mackell JA; Sun Y; Kassalow LM; Xu Y; McRae T; Li H
    J Natl Med Assoc; 2008 Nov; 100(11):1350-8. PubMed ID: 19024233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Regional Cortical Thickness Rate of Change in Donepezil-Treated Subjects With Suspected Prodromal Alzheimer's Disease.
    Cavedo E; Dubois B; Colliot O; Lista S; Croisile B; Tisserand GL; Touchon J; Bonafe A; Ousset PJ; Rouaud O; Ricolfi F; Vighetto A; Pasquier F; Galluzzi S; Delmaire C; Ceccaldi M; Girard N; Lehericy S; Duveau F; Chupin M; Sarazin M; Dormont D; Hampel H;
    J Clin Psychiatry; 2016 Dec; 77(12):e1631-e1638. PubMed ID: 27780331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropsychiatric symptoms and cholinergic therapy for Alzheimer's disease.
    Levy ML; Cummings JL; Kahn-Rose R
    Gerontology; 1999; 45 Suppl 1():15-22. PubMed ID: 9876214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disease state changes and safety of long-term donepezil hydrochloride administration in patients with Alzheimer's disease: Japan-Great Outcome of Long-term trial with Donepezil (J-GOLD).
    Arai H; Hashimoto N; Sumitomo K; Takase T; Ishii M
    Psychogeriatrics; 2018 Sep; 18(5):402-411. PubMed ID: 29993162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetylcholine muscarinic receptors and response to anti-cholinesterase therapy in patients with Alzheimer's disease.
    Brown D; Chisholm JA; Owens J; Pimlott S; Patterson J; Wyper D
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):296-300. PubMed ID: 12552349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.